Qube Research & Technologies (QRT)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.5M Sell
407,100
-293,100
-42% -$68.3M 0.11% 222
2025
Q4
$145M Buy
700,200
+392,900
+128% +$77.7M 0.15% 141
2025
Q3
$57M Sell
307,300
-571,800
-65% -$98M 0.06% 411
2025
Q2
$134M Buy
879,100
+335,700
+62% +$51.6M 0.14% 182
2025
Q1
$90.1M Sell
543,400
-16,900
-3% -$2.64M 0.1% 247
2024
Q4
$81M Buy
560,300
+127,900
+30% +$19.8M 0.11% 236
2024
Q3
$70.1M Buy
432,400
+162,600
+60% +$25.9M 0.1% 245
2024
Q2
$39.4M Buy
269,800
+74,600
+38% +$11.1M 0.06% 366
2024
Q1
$30.9M Sell
195,200
-283,600
-59% -$45.1M 0.05% 433
2023
Q4
$75M Buy
478,800
+335,700
+235% +$51.5M 0.15% 170
2023
Q3
$22.3M Buy
143,100
+68,100
+91% +$11.2M 0.06% 389
2023
Q2
$12.4M Hold
75,000
0.05% 473
2023
Q1
$11.6M Sell
75,000
-130,000
-63% -$21M 0.05% 420
2022
Q4
$36.2M Buy
205,000
+75,000
+58% +$12.9M 0.19% 125
2022
Q3
$21.2M Buy
+130,000
New +$22M 0.13% 222

Other funds holding JNJ

Qube Research & Technologies (QRT)'s JNJ Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of Johnson & Johnson (JNJ) in Q1 2026, closing a stake of 1,004,891 shares — an estimated $234M sold.

Qube Research & Technologies (QRT) first reported a position in JNJ in Q1 2018 and held it in 28 quarters. The position peaked at $570M in Q4 2024. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining Johnson & Johnson position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,004,891 Johnson & Johnson shares in Q1 2026, an estimated $234M.
  • Qube Research & Technologies (QRT) first reported a position in Johnson & Johnson in Q1 2018 and held it in 28 quarters.
  • Qube Research & Technologies (QRT)'s Johnson & Johnson position peaked at $570M in Q4 2024.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.